Market News
2 min read | Updated on March 06, 2024, 13:25 IST
SUMMARY
Mukka Proteins IPO allotment was finalised on Tuesday, March 5, after a bumper response from investors during its three-day subscription, which closed on March 4.
Mukka Proteins IPO share allotment status: 5 Key things to know
The ₹224 crore Mukka Proteins IPO was oversubscribed by nearly 137 times, reflecting an overwhelming response, particularly from institutional investors. Qualified institutional buyers’ (QIB) portion was subscribed around 189 times at the close of the offer. Non-institutional investors’ portion was bought 250 times, while the retail portion received 58.52 times subscription.
After a blockbuster performance during the subscription stage, investors have been allocated IPO shares. Refunds have been initiated on March 6.
Successful subscribers have been notified by the company about share allotment through emails and SMS. Investors can easily check Mukka Proteins allotment status online through BSE and registrar's websites.
Cameo Corporate Services Ltd is the registrar to the public issue.
Mukka Proteins shares will be listed on the NSE and BSE on March 7, 2024.
The ₹224-crore public offer of Mukka Proteins received applications for a total of 766.57 crore equity shares against 5.6 crore shares on offer.
Ahead of the IPO launch, Mukka Proteins raised ₹67 crore from anchor investors on February 28, 2024.
Mukka Proteins IPO price band was fixed at ₹26-28 per share. The IPO lot size was 535 shares and the minimum investment amount for retail investors was ₹13,910.
The initial share sale of Mukka Proteins comprised a fresh issue of 5,60,00,435 equity shares. There was no Offer for Sale (OFS) component.
About The Author
Next Story